CCJ · Cameco Corporation

The thesis

Cameco's case still rests on higher uranium contract prices and a possible Westinghouse stock-market listing, but the shares have slid below the July trading range and a fresh analyst target cut leaves the 30 October 2026 third-quarter report as the event that decides it. The adjusted close was $82.02 on 21 October 2026, 38.8% below the 52-week high of $134.09.

The narrative is maturing: the Westinghouse listing story has been public since Cameco's 31 July 2026 announcement, no public filing has been confirmed, and the shares have drifted lower since then. Barclays kept Equal-Weight on 19 October 2026 and lowered its price target to $95, according to Benzinga. The 14-day relative strength index, a 0–100 gauge of recent buying versus selling, was 43.4 on 21 October 2026, up from 24.5 on 25 September 2026 but still below the midpoint of 50.

Cameco owns 49% of Westinghouse. Bloomberg reported on 18 September 2026, citing unnamed people, that Westinghouse is seeking a valuation above US$50 billion and could file publicly as soon as October. No offering size or price range has been published. A weekly close above $106.33, the 27 August 2026 reference close, would contradict the view that interest has stalled.

Bullish and bearish views on Cameco Corporation

The bull case on Cameco Corporation (CCJ), in brief: Contract prices are rising. The bear case: Earnings fell despite higher prices.

Bull case

• Contract prices are rising. On 31 July 2026 Cameco raised its expected 2026 realized uranium price to C$91–96 per pound from C$85–89. That outlook is in Canadian dollars; the third-quarter report shows whether deliveries confirm it.
• Westinghouse offers a visible valuation event. Cameco said on 31 July 2026 that Westinghouse had confidentially submitted a draft US registration statement. Bloomberg's 18 September 2026 report of a valuation aim above US$50 billion stays unconfirmed until a public filing appears.
• Production guidance held. Cameco kept 2026 attributable production guidance at 19.5–21.5 million pounds on 31 July 2026.
• Most published targets sit well above the price. Jefferies initiated at Buy with a C$190 target on 3 September 2026. Truist kept Buy and raised its target to $130 on 12 August 2026. Even Barclays' lowered $95 target of 19 October 2026 is above the $82.02 close.

Bear case

• Earnings fell despite higher prices. Cameco's second-quarter revenue was C$814 million, down 7% from a year earlier, reported 31 July 2026. TIKR and Yahoo Finance headlines described uranium earnings as falling nearly 40% in the quarter despite 18% higher prices.
• Targets are being cut. Barclays lowered its target to $95 on 19 October 2026, after moving to Equal-Weight with a $104 target on 16 July 2026 (Benzinga).
• The share price trend is down. The adjusted close fell from $96.68 on 11 September 2026 to $88.07 on 25 September 2026, $87.12 on 8 October 2026 and $82.02 on 21 October 2026. That is below the July trading range of roughly $85–88.
• The listing may not deliver the headline value. The Westinghouse offering has no confirmed date, share count or price range. A filing below the reported valuation aim, or a delay into 2027, would weaken the main near-term catalyst.
• Cameco sells uranium into US utilities from Canadian mines.

Price setup

The adjusted close was $82.02 on 21 October 2026. The 52-week high is $134.09, the three-month price change is −6.6%, and the 14-day relative strength index is 43.4. The shares closed below the July range of roughly $85–88, and the next marked level below is the $68.96 prior low.

A Benzinga headline on 13 October 2026 said speculators were loading on uranium. Retail and speculative attention is therefore present while the shares fall, and the third-quarter report arrives on 30 October 2026, nine days after the latest close. A weekly close back above $88 would put the shares inside the July range again; $106.33 is the 27 August 2026 reference close.

Catalysts, next 30 days

• ~2026-10 (est.): Possible public filing of Westinghouse's US registration statement. A filed share count and price range would show whether the reported US$50 billion valuation aim has support.
• 30 October 2026: Cameco third-quarter results before markets open. Deliveries, realized uranium prices and production guidance show whether higher contract prices are reaching earnings. Revenue against the prior-year quarter matters after the 7% second-quarter decline.

What would change the view

The case breaks if the shares close below the $68.96 prior low region or if the third-quarter report shows contract repricing is not reaching earnings. A cut to 2026 attributable production guidance below 19.5–21.5 million pounds would also break it. A Westinghouse filing that implies a value well under US$50 billion, or no public filing by year-end, would weaken the listing leg of the case.

The case strengthens if third-quarter revenue exceeds the prior-year level and the realized price outlook of C$91–96 per pound holds or rises. A public Westinghouse filing with terms consistent with the Bloomberg valuation report would do the same.

What it trades with

Cameco trades with the uranium and nuclear group. The VanEck Uranium and Nuclear ETF rose 16% in August 2026, its best month since January, according to Benzinga on 25 August 2026. Cameco lagged that move: its adjusted close fell from $96.68 on 11 September 2026 to $82.02 on 21 October 2026.

The shares also react to power-demand news, such as the 6 October 2026 report of a 20-year Google agreement tied to Constellation Energy's reactors, and to US–Canada trade headlines. Cameco's Westinghouse stake ties part of its value to the nuclear-services and reactor-build market as well as to uranium prices.